Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' ASENBAUM S' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 56 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Cunnington, R; Lalouschek, W; Dirnberger, G; Walla, P; Lindinger, G; Asenbaum, S; Brucke, T; Lang, W
      A medial to lateral shift in pre-movement cortical activity in hemi-Parkinson's disease

      CLINICAL NEUROPHYSIOLOGY
    2. Stamenkovic, M; Schindler, SD; Asenbaum, S; Neumeister, A; Willeit, M; Willinger, U; de Zwaan, M; Riederer, F; Aschauer, HN; Kasper, S
      No change in striatal dopamine re-uptake site density in psychotropic drugnaive and in currently treated Tourette's disorder patients: a [I-123]-beta-CIT SPECT-study

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    3. Asenbaum, S; Baumgartner, C
      Nuclear medicine in the preoperative evaluation of epilepsy

      NUCLEAR MEDICINE COMMUNICATIONS
    4. Neumeister, A; Willeit, M; Praschak-Rieder, N; Asenbaum, S; Stastny, J; Hilger, E; Pirker, W; Konstantinidis, A; Kasper, S
      Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls

      PSYCHOLOGICAL MEDICINE
    5. Voller, B; Vass, K; Wanschitz, J; Machold, K; Asenbaum, S; Hoberstorfer, M; Auff, E
      Hypertrophic chronic pachymeningitis as a localized immune process in the craniocervical region

      NEUROLOGY
    6. Willeit, M; Stastny, J; Pirker, W; Praschak-Rieder, N; Neumeister, A; Asenbaum, S; Tauscher, J; Fuchs, K; Sieghart, W; Hornik, K; Aschauer, HN; Brucke, T; Kasper, S
      No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism

      BIOLOGICAL PSYCHIATRY
    7. Tauscher, J; Pirker, W; Willeit, M; de Zwaan, M; Bailer, U; Neumeister, A; Asenbaum, S; Lennkh, C; Praschak-Rieder, N; Brucke, T; Kasper, S
      [I-123] beta-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa

      BIOLOGICAL PSYCHIATRY
    8. Barnas, C; Quiner, S; Tauscher, J; Hilger, E; Willeit, M; Kufferle, B; Asenbaum, S; Brucke, T; Rao, ML; Kasper, S
      In vivo I-123 IBZM SPECT imaging of striatal dopamine 2 receptor occupancyin schizophrenic patients

      PSYCHOPHARMACOLOGY
    9. Sauter, C; Asenbaum, S; Popovic, R; Bauer, H; Lamm, C; Klosch, G; Zeitlhofer, J
      Excessive daytime sleepiness in patients suffering from different levels of obstructive sleep apnoea syndrome

      JOURNAL OF SLEEP RESEARCH
    10. Pirker, W; Asenbaum, S; Bencsits, G; Prayer, D; Gerschlager, W; Deecke, L; Brucke, T
      [I-123]beta-CIT SPECT in multiple system atrophy, progressive supranuclearpalsy, and corticobasal degeneration

      MOVEMENT DISORDERS
    11. Brucke, T; Djamshidian, S; Bencsits, G; Pirker, W; Asenbaum, S; Podreka, I
      SPECT and PET imaging of the dopaminergic system in Parkinson's disease

      JOURNAL OF NEUROLOGY
    12. Pirker, W; Asenbaum, S; Hauk, M; Kandlhofer, S; Tauscher, J; Willeit, M; Neumeister, A; Praschak-Rieder, N; Angelberger, P; Brucke, T
      Imaging serotonin and dopamine transporters with I-123-beta-CIT SPECT: Binding kinetics and effects of normal aging

      JOURNAL OF NUCLEAR MEDICINE
    13. Willeit, M; Praschak-Rieder, N; Neumeister, A; Pirker, W; Asenbaum, S; Vitouch, O; Tauscher, J; Hilger, E; Stastny, J; Brucke, T; Kasper, S
      [I-123]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder

      BIOLOGICAL PSYCHIATRY
    14. Neumeister, A; Pirker, W; Willeit, M; Praschak-Rieder, N; Asenbaum, S; Brucke, T; Kasper, S
      Seasonal variation of availability of serotonin transporter binding sites in healthy female subjects as measured by [I-123]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography

      BIOLOGICAL PSYCHIATRY
    15. Tauscher, J; Pirker, W; de Zwaan, M; Asenbaum, S; Brucke, T; Kasper, S
      In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    16. Pirker, W; Baumgartner, C; Brugger, S; Prayer, D; Kandlhofer, S; Asenbaum, S; Deecke, L; Brucke, T; Lange, KW
      Severe akinetic syndrome resulting from a bilateral basal ganglia lesion following bone marrow transplantation

      MOVEMENT DISORDERS
    17. Feucht, M; Moller, U; Witte, H; Benninger, F; Asenbaum, S; Prayer, D; Friedrich, MH
      Application of correlation dimension and pointwise dimension for non-linear topographical analysis of focal onset seizures

      MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING
    18. Baumgartner, C; Olbrich, A; Lindinger, G; Pataraia, E; Groppel, G; Bacher, J; Aull, S; Serles, W; Hoffmann, M; Leutmezer, F; Czech, T; Prayer, D; Pietrzyk, U; Asenbaum, S; Podreka, I
      Regional cerebral blood flow during temporal lobe seizures associated withictal vomiting: An ictal SPECT study in two patients

      EPILEPSIA
    19. Tauscher, J; Kufferle, B; Asenbaum, S; Fischer, P; Pezawas, L; Barnas, C; Tauscher-Wisniewski, S; Brucke, T; Kasper, S
      In vivo I-123 IBZM SPECT imaging of striatal dopamine-2 receptor occupancyin schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol

      PSYCHOPHARMACOLOGY
    20. WILLEIT M; BARNAS C; TAUSCHER J; KUFFERLE B; KRENN P; ASENBAUM S; BRUCKE T; KASPER S
      VISUALIZATION OF DOPAMINE-2 RECEPTOR BLOCKADE IN PSYCHOTIC-PATIENTS TREATED WITH ZOTEPINE

      Schizophrenia research
    21. Wober, C; Zeitlhofer, J; Asenbaum, S; Claeys, L; Czerny, M; Wolfl, G; Grubhofer, G; Polterauer, P; Deecke, L
      Monitoring of median nerve somatosensory evoked potentials in carotid surgery

      JOURNAL OF CLINICAL NEUROPHYSIOLOGY
    22. Asenbaum, S; Pirker, W; Angelberger, P; Bencsits, G; Pruckmayer, M; Brucke, T
      [I-123]beta-CIT and SPECT in essential tremor and Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    23. ASENBAUM S; BRUCKE T; PIRKER W; PIETRZYK U; PODREKA I
      IMAGING OF CEREBRAL BLOOD-FLOW WITH TECHNETIUM-99M-HMPAO AND TECHNETIUM-99M-ECD - A COMPARISON

      The Journal of nuclear medicine
    24. KAPPOS L; POLMAN C; POZZILLI C; THOMPSON A; DAHLKE F; KNIGHT R; HERN J; COLEMAN R; GERRIE L; COOPER G; MOORE J; BORINGA J; VANOOSTEN B; RONNER H; SCHRIJVER H; TRUYEN L; MONTALBAN J; RIO J; TINTORE M; JACAS C; MARZO E; LECHNERSCOTT J; HUBER S; LIENERT C; BRUNNSCHWEILER H; HAWKINS S; DROOGAN A; MCDONNELL G; DUDDY M; MCKINSTRY S; ALTENKIRCH H; BAUM K; EINHAUPL K; MARX P; POEWE W; WALTER G; AKMAN H; BROCKMEIER B; SCHERER P; ZSCHENDERLEIN R; SCHMIERER K; GELDERBLOM H; HARTMANN A; STAPF C; LUSCHOW A; MACKERT B; SCHUMACHER H; MASUHR F; HEMPEL T; ZIMMERMANN R; MUNCH M; FRANCIS D; HEAFIELD M; ALMEMAR A; WINER J; CHONG M; BROCHET B; GAYOU A; AURIACOMBE S; DOUSSET V; WILES C; THOMAS F; PICKERSGILL T; HINDS N; DAWSON K; HUGHES T; HUTCHINSON M; MURPHY R; REDMOND J; WEBB S; STOLL G; JANDER S; HAGEMANN G; KOLLER H; HANEMANN C; KOLMEL H; REICHEL D; PETEREIT K; THIEME A; KHATAMI A; NEUMANN M; AMADUCCI L; MASSACESI L; SIRACUSA G; AMATO M; BARTOLOZZI L; REPICE A; MINDERHOUD J; DEKEYSER J; ZORGDRAGER A; ZWANIKKEN C; POSER S; POLAK T; GUNTHER A; BITSCH A; BORNER T; WEBER F; WIKSTROM J; FARKKILA M; MAJURI H; SUMELAHTI M; TELAKIVI T; FREDRIKSON S; MARTIN C; MILLER D; ORIORDAN J; BREX P; KAPOOR R; WERRING D; CONFAVREUX C; BRUNET P; HANNOUN D; BRUDON F; MOREAU T; BLANC S; DHOOGHE M; JACOBS K; LISSOIR F; DEMONTY L; COMI G; COLOMBO B; ROSSI P; RODEGHER M; SANTUCCIO G; MARTINELLI F; HOHLFELD R; WALTHER E; GOEBELS N; DANG T; LINDERT R; VOLTZ R; CARTLIDGE N; BATES D; MORAN G; PANDIT L; WESTWOOD M; HALLER P; SOMMER J; BITTER J; SUSS F; MELLIES J; MUCHA P; LYONCAEN O; DEGOS JD; ROULLET E; LUBETZKI C; CREANGE A; TOURBAH A; PEZ D; LECANUET P; NICOLT P; EDAN G; BELLIARD S; DEMARCO O; CAHAGNE V; DEBURGHGRAEVE V; BRUNET I; FIESCHI C; MILLEFIORINI E; GASPERINI C; BUTTINELLI C; FRONTINI M; HOWELL S; HADJIVASSILIOU M; GIBSON A; GRAHAM A; HARKNESS K; LAWDEN M; CLANET M; WAUBAN E; AZAISVUILLEMIN C; LAU G; LOUIS C; PANELIUS M; RUUTIAINEN J; ERALINNA J; SOILUHANNINEN M; GOLD R; HARTUNG HP; JUNG S; BAYAS A; FLACHENECKER P; WEILBACH F; ARCHELOS J; KOLLEGGER H; VASS K; ASENBAUM S; CHATSAKOS T; BECKMANN K; GHAZI M; WAGNER K; MILTENBURGER C; MCFARLAND H; PETKAU J; SABOURAUD O; TOYKA K
      PLACEBO-CONTROLLED MULTICENTER RANDOMIZED TRIAL OF INTERFERON BETA-1BIN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS

      Lancet
    25. PRASCHAKRIEDER N; NEUMEISTER A; WILLEIT M; PODREKA I; VITOUCH O; ASENBAUM S; KASPER S
      HMPAO-SPECT IN SAD PATIENTS BEFORE AND AFTER LIGHT THERAPY

      Biological psychiatry
    26. KASPER S; TAUSCHER J; KUFFERLE B; BARNAS C; HESSELMANN B; ASENBAUM S; PODREKA I; BRUCKE T
      SERTINDOLE AND DOPAMINE D-2 RECEPTOR OCCUPANCY IN COMPARISON TO RISPERIDONE, CLOZAPINE AND HALOPERIDOL - A I-123 IBZM SPECT STUDY

      Psychopharmacology
    27. ZEITLHOFER J; GRUBER G; ANDERER P; ASENBAUM S; SCHIMICEK P; SALETU B
      TOPOGRAPHIC DISTRIBUTION OF SLEEP SPINDLES IN YOUNG HEALTHY-SUBJECTS

      Journal of sleep research
    28. BRUCKE T; ASENBAUM S; PIRKER W; DJAMSHIDIAN S; WENGER S; WOBER C; MULLER C; PODREKA I
      MEASUREMENT OF THE DOPAMINERGIC DEGENERATION IN PARKINSONS-DISEASE WITH [I-123] BETA-CIT AND SPECT - CORRELATION WITH CLINICAL FINDINGS ANDCOMPARISON WITH MULTIPLE SYSTEM ATROPHY AND PROGRESSIVE SUPRANUCLEAR PALSY

      Journal of neural transmission. Supplementum
    29. PIRKER W; ASENBAUM S; WENGER S; KORNHUBER J; ANGELBERGER P; DEECKE L; PODREKA I; BRUCKE T
      IODINE-123-EPIDEPRIDE-SPECT - STUDIES IN PARKINSONS-DISEASE, MULTIPLESYSTEM ATROPHY AND HUNTINGTONS-DISEASE

      The Journal of nuclear medicine
    30. ASENBAUM S; BRUCKE T; PIRKER W; PODREKA I; ANGELBERGER P; WENGER S; WOBER C; MULLER C; DEECKE L
      IMAGING OF DOPAMINE TRANSPORTERS WITH IODINE-123-BETA-CIT AND SPECT IN PARKINSONS-DISEASE

      The Journal of nuclear medicine
    31. STEPANSKY R; ASENBAUM S; SALETU B; ZEITLHOFER J
      NEUROLOGICAL SLEEP DISTURBANCES - HYPERSO MNIAS

      Wiener Klinische Wochenschrift
    32. TAUSCHER J; KUFFERLE B; BARNAS C; ASENBAUM S; BRUCKE T; KASPER S
      D-2 RECEPTOR OCCUPANCY WITH QUETIAPINE, CLOZAPINE, RISPERIDONE AND HALOPERIDOL

      Biological psychiatry
    33. TAUSCHER J; KUFFERLE B; BARNAS C; ASENBAUM S; BRUCKE T; KASPER S
      PREMEDICATION INFLUENCED D-2 RECEPTOR OCCUPANCY WITH QUETIAPINE AND SERTINDOLE

      Biological psychiatry
    34. WILLEIT M; PRASCHAKRIEDER N; ASENBAUM S; NEUMEISTER A; HESSELMANN B; HABELER A; IBATOULLINA E; TAUSCHER J; PIRKER W; BRUCKE T; KASPER S
      SEROTONIN TRANSPORTER DENSITY IN DEPRESSED SAD PATIENTS

      Biological psychiatry
    35. KASPER S; KUFFERLE B; TAUSCHER J; ASENBAUM S; BARNAS C; HESSELMANN B; PODREKA I; BRUCKE T
      DOPAMINE D-2 RECEPTOR-BINDING IN TYPICAL AND ATYPICAL NEUROLEPTICS

      Biological psychiatry
    36. KUFFERLE B; TAUSCHER J; ASENBAUM S; VESELY C; PODREKA I; BRUCKE T; KASPER S
      IBZM SPECT IMAGING OF STRIATAL DOPAMINE-2 RECEPTORS IN PSYCHOTIC-PATIENTS TREATED WITH THE NOVEL ANTIPSYCHOTIC SUBSTANCE QUETIAPINE IN COMPARISON TO CLOZAPINE AND HALOPERIDOL

      Psychopharmacology
    37. TAUSCHER J; KUFFERLE B; ASENBAUM S; BRUCKE T; KASPER S
      PREVIOUS TREATMENT AS A CONFOUNDING VARIABLE IN STUDIES WITH NOVEL ANTIPSYCHOTICS - 2 CASES OF HIGH DOPAMINE-2 RECEPTOR OCCUPANCY WITH QUETIAPINE

      Psychopharmacology
    38. KUFFERLE B; BRUCKE T; TOPITZSCHRATZBERGER A; TAUSCHER J; GOSSLER R; VESELY C; ASENBAUM S; PODREKA I; KASPER S
      STRIATAL DOPAMINE-2 RECEPTOR OCCUPANCY IN PSYCHOTIC-PATIENTS TREATED WITH RISPERIDONE

      PSYCHIATRY RESEARCH-NEUROIMAGING
    39. ODER W; BRUCKE T; KOLLEGGER H; SPATT J; ASENBAUM S; DEECKE L
      DOPAMINE D2 RECEPTOR-BINDING IS REDUCED IN WILSONS-DISEASE - CORRELATION OF NEUROLOGICAL DEFICITS WITH STRIATAL I-123 IODOBENZAMIDE BINDING

      Journal of neural transmission
    40. PIRKER W; RIEDL M; LUGER A; CZECH T; ROSSLER K; ASENBAUM S; ANGELBERGER P; KORNHUBER J; DEECKE L; PODREKA I; BRUCKE T
      DOPAMINE D2 RECEPTOR IMAGING IN PITUITARY-ADENOMAS USING IODINE-123-EPIDEPRIDE AND SPECT

      The Journal of nuclear medicine
    41. TAUSCHER J; KUFFERLE B; NEUMEISTER A; ASENBAUM S; BRUCKE T; PODREKA I; KASPER S
      IBZM-SPECT SHOWS LOW STRIATAL D2 BLOCKADE UNDER THERAPY WITH SEROQUEL

      Biological psychiatry
    42. KASPER S; TAUSCHER J; KUFFERLE B; HEIDEN A; NEUMEISTER A; BARNAS C; ASENBAUM S; PODREKA I; BRUCKE T
      D2 - RECEPTOR IMAGING (SPECT) AS A TOOL FOR MEASURING THE EFFICACY AND SIDE-EFFECT PROFILE OF TREATMENT WITH NEUROLEPTICS

      Biological psychiatry
    43. KORNHUBER J; BRUCKE T; ANGELBERGER P; ASENBAUM S; PODREKA I
      SPECT IMAGING OF DOPAMINE-RECEPTORS WITH [I-123] EPIDEPRIDE - CHARACTERIZATION OF UPTAKE IN THE HUMAN BRAIN

      Journal of neural transmission
    44. PIRKER W; ASENBAUM S; KASPER S; WALTER H; ANGELBERGER P; KOCH G; POZZERA A; DEECKE L; PODREKA I; BRUCKE T
      BETA-CIT SPECT DEMONSTRATES BLOCKADE OF 5HT-UPTAKE SITES BY CITALOPRAM IN THE HUMAN BRAIN IN-VIVO

      Journal of neural transmission
    45. BRUCKE T; WOBER C; PODREKA I; WOBERBINGOL C; ASENBAUM S; AULL S; WENGER S; ILIEVA D; HARASKOVANDERMEER C; WESSELY P; DEECKE L
      D-2 RECEPTOR BLOCKADE BY FLUNARIZINE AND CINNARIZINE EXPLAINS EXTRAPYRAMIDAL SIDE-EFFECTS - A SPECT STUDY

      Journal of cerebral blood flow and metabolism
    46. ASENBAUM S; ZEITLHOFER J; SALETU B; FREY R; BRUCKE T; PODREKA I; DEECKE L
      TECHNETIUM-99M-HMPAO SPECT IMAGING OF CEREBRAL BLOOD-FLOW DURING REM-SLEEP IN NARCOLEPTICS

      The Journal of nuclear medicine
    47. LEHRNER J; BRUCKE T; KRYSPINEXNER I; ASENBAUM S; PODREKA I
      IMPAIRED OLFACTORY FUNCTION IN PARKINSONS-DISEASE

      Lancet
    48. ASENBAUM S; REINPRECHT A; BRUCKE T; WENGER S; PODREKA I; DEECKE L
      A STUDY OF ACETAZOLAMIDE-INDUCED CHANGES IN CEREBRAL BLOOD-FLOW USINGTC-99M HMPAO SPECT IN PATIENTS WITH CEREBROVASCULAR-DISEASE

      Neuroradiology
    49. ASENBAUM S; ZEITLHOFER J; DEECKE L
      PSYCHIC COMPLICATIONS FOLLOWING GYNECOLOG ICAL SURGERY

      Der Gynakologe
    50. GERMANN P; VLACH W; GARADA B; LEITHA T; ASENBAUM S; FARYNIAK B; LEITNER C; URAK G; ZIMPFER M
      ANNULAR SINGLE-CRYSTAL PHOTON-EMISSION COMPUTED-TOMOGRAPHY (ASPECT) IN THE ICU - INITIAL EXPERIENCE

      Anesthesiology
    51. WOBER C; BRUCKE T; WOBERBINGOL C; ASENBAUM S; WESSELY P; PODREKA I
      DOPAMINE-D2 RECEPTOR BLOCKADE AND ANTIMIGRAINE ACTION OF FLUNARIZINE

      Cephalalgia
    52. PIRKER W; BRUCKE T; RIEDL M; CLODI M; LUGER A; ASENBAUM S; PODREKA I; DEECKE L
      IODINE-123-IBZM-SPECT - STUDIES IN 15 PATIENTS WITH PITUITARY-TUMORS

      Journal of neural transmission
    53. BRUCKE T; ASENBAUM S; ANGELBERGER P; KOMHUBER J; POZZERA A; HORNYKIEWICZ S; HARASKOVANDERMEER C; WENGER S; PIRKER W; PODREKA I
      QUANTIFICATION OF THE DOPAMINERGIC NERVE-CELL LOSS IN PARKINSONS-DISEASE WITH [I-123] LABELED BETA-CIT AND SPECT

      The Journal of nuclear medicine
    54. SCHIMA W; WIMBERGER D; SCHNEIDER B; STIGLBAUER R; ASENBAUM S; IMHOF H
      FIELD-STRENGTH IN MR-IMAGING OF MULTIPLE- SCLEROSIS - A COMPARISON OF0.5 AND 1.5T

      RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren
    55. BRUCKE T; KORNHUBER J; ANGELBERGER P; ASENBAUM S; FRASSINE H; PODREKA I
      SPECT IMAGING OF DOPAMINE AND SEROTONIN TRANSPORTERS WITH [I-123] BETA-CIT - BINDING-KINETICS IN THE HUMAN BRAIN

      Journal of neural transmission
    56. ZEITLHOFER J; ASENBAUM S; SPISS C; WIMMER A; MAYR N; WOLNER E; DEECKE L
      CENTRAL-NERVOUS-SYSTEM FUNCTION AFTER CARDIOPULMONARY BYPASS

      European heart journal


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/05/19 alle ore 13:11:19